iopamidol has been researched along with Xanthoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handra-Luca, A | 1 |
| Hasuo, K; Kamitani, T; Koizuka, H; Nishimiya, M; Shida, Y; Takahashi, N | 1 |
2 other study(ies) available for iopamidol and Xanthoma
| Article | Year |
|---|---|
Xanthomatous Interstitial Pneumopathy: Chemotherapy- or Contrast Substance Related Change?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Xanthomatosis | 2020 |
Xanthogranulomatous pancreatitis associated with intraductal papillary mucinous tumor.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Contrast Media; Gadolinium DTPA; Granuloma; Humans; Iopamidol; Magnetic Resonance Imaging; Male; Pancreatic Neoplasms; Pancreatitis; Tomography, X-Ray Computed; Xanthomatosis | 2005 |